Additional file 1: Figure S1. of Development of a surrogate potency assay to determine the angiogenic activity of StempeucelŽ, a pooled, ex-vivo expanded, allogeneic human bone marrow mesenchymal stromal cell product Charan Thej Balamurugan Ramadasse Ankita Walvekar Anish Majumdar Sudha Balasubramanian 10.6084/m9.figshare.c.3705505_D1.v1 https://springernature.figshare.com/articles/figure/Additional_file_1_Figure_S1_of_Development_of_a_surrogate_potency_assay_to_determine_the_angiogenic_activity_of_Stempeucel_a_pooled_ex-vivo_expanded_allogeneic_human_bone_marrow_mesenchymal_stromal_cell_product/4705666 showing a characterization of phBMMSCs for MSC-positive surface markers (CD44, CD73, CD90, CD105 and CD166) and negative markers (CD14, CD19, CD34, CD45, CD133 and HLA-DR), and indication of viability (inset), by flow cytometry; b differentiation of phBMMSCs into adipocytes, osteocytes and chondrocytes, stained with Oil Red O, Alizarin Red and Saffranin O, respectively. (TIF 6151 kb) 2017-02-28 05:00:00 Potency assay Angiogenesis Pooled human bone marrow-derived mesenchymal stromal cell Vascular endothelial growth factor Endothelial tube formation